KoBioLabs, Inc (KOSDAQ:348150)
South Korea
· Delayed Price · Currency is KRW
5,530.00
+70.00 (1.28%)
At close: Dec 5, 2025
KoBioLabs Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 107,386 | 103,844 | 160,602 | 191,231 | 335,174 | 672,727 | |
| Market Cap Growth | -14.59% | -35.34% | -16.02% | -42.95% | -50.18% | - | |
| Enterprise Value | 89,189 | 80,193 | 121,886 | 127,584 | 294,643 | 650,116 | |
| Last Close Price | 5530.00 | 5360.00 | 8510.00 | 11050.00 | 20600.00 | 43350.00 | |
| PS Ratio | 1.50 | 1.52 | 4.85 | 16.48 | 115.84 | 146.52 | |
| PB Ratio | 2.15 | 1.87 | 2.60 | 2.00 | 3.70 | 12.15 | |
| P/TBV Ratio | 3.37 | 2.79 | 3.65 | 2.51 | 3.75 | 12.21 | |
| EV/Sales Ratio | 1.24 | 1.17 | 3.68 | 10.99 | 101.84 | 141.59 | |
| Debt / Equity Ratio | 0.28 | 0.30 | 0.30 | 0.14 | 0.10 | 0.00 | |
| Asset Turnover | 0.73 | 0.63 | 0.28 | 0.10 | 0.04 | 0.10 | |
| Inventory Turnover | 3.87 | 7.27 | 7.72 | 5.88 | 5.50 | 17.11 | |
| Quick Ratio | 4.19 | 4.28 | 3.36 | 10.95 | 13.45 | 18.17 | |
| Current Ratio | 4.78 | 4.82 | 3.58 | 11.46 | 14.42 | 18.71 | |
| Return on Equity (ROE) | -12.04% | -7.87% | -19.28% | -25.14% | -21.07% | -1173.43% | |
| Return on Assets (ROA) | -5.24% | -3.98% | -9.67% | -11.07% | -12.47% | -16.44% | |
| Return on Capital (ROIC) | -7.50% | -5.67% | -12.19% | -12.13% | -13.15% | -161.09% | |
| Return on Capital Employed (ROCE) | -10.30% | -7.80% | -19.70% | -17.60% | -16.60% | -22.30% | |
| Earnings Yield | -6.10% | -5.10% | -8.63% | -11.46% | -4.59% | -8.19% | |
| FCF Yield | -6.51% | -5.77% | -18.04% | -16.34% | -5.37% | -1.92% | |
| Buyback Yield / Dilution | -1.36% | -3.54% | -10.30% | -4.68% | -49.69% | -51.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.